Technology | Radial Access | February 17, 2017

February 17, 2017 — Medtronic plc announced that its coronary portfolio will now include the DxTerity Diagnostic...

Sponsored Content | Videos | Inventory Management | February 17, 2017

The supplies you use in your cath lab are complex and very valuable. Protecting your investment and uncovering new...

Mercator MedSystems, DANCE trial data, ISET, LINC, Bullfrog Micro-Infusion Device
News | Peripheral Arterial Disease (PAD) | February 15, 2017

February 15, 2017 — Mercator MedSystems announced that the national co-principal investigators of the company’s...

University of Alabama at Birmingham, Amplatzer PFO Occluder, first implementation
News | Structural Heart Occluders | February 15, 2017

February 15, 2017 — Doctors at the University of Alabama at Birmingham have implemented the first U.S. Food and Drug...

Biotronik, PRO-Kinetic Energy cobalt chromium coronary stent system, FDA approval
Technology | Stents Bare Metal | February 15, 2017

February 15, 2017 — The PRO-Kinetic Energy Cobalt Chromium (CoCr) Coronary Stent System from Biotronik has gained U....

heart team, hybird OR, structural heart team

The heart team approach was first used on a large scale in the CoreValve and Sapien TAVR trials and helped lead to excellent outcomes in high-risk patients.

Feature | Hybrid OR | February 15, 2017 | Dave Fornell

In the current era of healthcare reform and the push toward evidence-based medicine to both lower costs and improve...

HeartFlow FFRct Analysis, NICE guidance, U.K., United Kingdom, guidelines, stable chest pain
News | CT Angiography (CTA) | February 14, 2017

February 14, 2017 — The National Institute for Health and Care Excellence (NICE) in the United Kingdom recently...

Blog | Stents | February 13, 2017

Stents were the key focus of interventional cardiology for more than 20 years, but the focus has changed in recent...

News | Hypertension | February 13, 2017

February 13, 2017 — Vascular Dynamics Inc. (VDI) announced that the U.S. Food and Drug Administration (FDA) has...

 Intra-atrial shunt device (IASD) to lower left atrial pressure by creating a small left atrial to right atrial shunt.  Abraham said these devices are in early stage development with small studies to show proof of concept and demonstrate safety.

The Corvia Intra-atrial shunt device (IASD) lowers left atrial pressure by creating a small left atrial to right atrial shunt. Preliminary clinical studies have shown promise for these types of devices to improve HFpEF patient outcomes.

Feature | Heart Failure | February 10, 2017 | Dave Fornell

In the past few years there have been a number of device therapies developed to treat heart failure (HF). This is...

Videos | 3-D Printing | February 09, 2017

When a pediatric patient at Children’s Hospital Los Angeles needed a custom-build stent to repair his pulmonary...

Xarelto, rivaroxaban, COMPASS study, ends early,
News | Antiplatelet and Anticoagulation Therapies | February 09, 2017

February 9, 2017 — Janssen Research & Development LLC (Janssen) announced that the Phase 3 COMPASS trial is...

Medtronic, IDE approval, IN.PACT Admiral drug-coated balloon, DCB, end-stage renal disease
News | Drug-Eluting Balloons | February 08, 2017

February 8, 2017 — Medtronic plc announced receipt of an investigational device exemption (IDE) from the U.S. Food...

CSI, LIBERTY 360 Study, ISET 2017, six-month data, lower extremity PAD
News | Atherectomy Devices | February 08, 2017

February 8, 2017 — Cardiovascular Systems (CSI) presented six-month data from its LIBERTY 360° post-market study in...

Overlay Init